|
1
|
Bokemeyer C, Nichols CR, Droz JP, et al:
Extragonadal germ cell tumors of the mediastinum and
retroperitoneum: results from an international analysis. J Clin
Oncol. 20:1864–1873. 2002.
|
|
2
|
Cicin I, Saip P, Guney N, et al: Yolk sac
tumors of the ovary: evaluation of clinicopathological features and
prognostic factors. Eur J Obstet Gynecol Reprod Biol. 146:210–214.
2009.
|
|
3
|
Kurman RJ and Norris HJ: Malignant germ
cell tumor of the ovary. Hum Pathol. 8:551–564. 1977.
|
|
4
|
Mitchell PL, Al-Nasiri N, A’Hern R, et al:
Treatment of nondysgerminomatous ovarian germ cell tumors: an
analysis of 69 cases. Cancer. 85:2232–2244. 1999.
|
|
5
|
Gershenson DM, Morris M, Cangir A, et al:
Treatment of malignant germ cell tumours of the ovary with
bleomycin, etoposide, and cisplatin. J Clin Oncol. 8:715–720.
1990.
|
|
6
|
Williams S, Blessing JA, Liao SY, et al:
Adjuvant therapy of ovarian germ cell tumours with cisplatin,
etoposide, and bleomycin: a trial of the Gynecologic Oncology
Group. J Clin Oncol. 12:701–706. 1994.
|
|
7
|
Willemse PH, Aalders JG, Bouma J, et al:
Long-term survival after vinblastine, bleomycin, and cisplatin
treatment in patients with germ cell tumors in the ovary: an
update. Gynecol Oncol. 28:268–277. 1987.
|
|
8
|
Nawa A, Obata N, Kikkawa F, et al:
Prognostic factors of patients with yolk sac tumors of the ovary.
Am J Obstet Gynecol. 184:1182–1188. 2001.
|
|
9
|
Wada S, Yoshimura R, Nishisaka N, et al:
Primary retroperitoneal pure yolk-sac tumor in an adult male. Scand
J Urol Nephrol. 35:515–517. 2001.
|
|
10
|
DiPerna CA, Bowdish ME, Weaver FA, et al:
Concomitant vascular procedures for malignancies with vascular
invasion. Arch Surg. 137:901–906. 2002.
|
|
11
|
Peccatori F, Bonazzi C, Chiari S, et al:
Surgical management of malignant ovarian germ cell tumors: 10
years’ experience of 129 patients. Obstet Gynecol. 86:367–372.
1995.
|
|
12
|
Ayhan A, Bildirici I, Günalp S and Yuce K:
Pure dygerminoma of the ovary: a review of 45 well staged cases.
Eur J Gynecol Oncol. 21:98–101. 2000.
|
|
13
|
Zanagnolo V, Sartori E, Galleri G,
Pasinetti B and Bianchi U: Clinical review of 55 cases of malignant
ovarian germ cell tumors. Eur J Gynaecol Oncol. 25:315–320.
2004.
|
|
14
|
Talerman A, Haije WG and Baggerman L:
Serum alphafetoprotein (AFP) in patients with germ cell tumors of
the gonads and extragonadal sites: correlation between endodermal
sinus (yolk sac) tumor and raised serum AFP. Cancer. 46:380–385.
1980.
|
|
15
|
No authors listed. International Germ Cell
Consensus Classification: a prognostic factor-based staging system
for metastatic germ cell cancers. International Germ Cell Cancer
Collaborative Group. J Clin Oncol. 15:594–603. 1997.
|
|
16
|
Lertkhachonsuk R, Termrungruanglert W,
Vasuratna A, et al: Malignant ovarian germ cell tumor in King
Chulalongkorn Memorial Hospital. J Med Assoc Thai. 88:124–128.
2005.
|
|
17
|
Park S, Lee S, Lee J, et al: Salvage
chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in
relapsed or cisplatin-refractory germ cell tumors. Onkologie.
34:416–420. 2011.
|
|
18
|
Zanetta G, Bonazzi C, Cantù M, et al:
Survival and reproductive function after treatment of malignant
germ cell ovarian tumors. J C1in Oncol. 19:1015–1020. 2001.
|
|
19
|
Mayordomo JI, Paz-Ares L, Rivera F, et al:
Ovarian and extragonadal malignant germ-cell tumors in females: a
single-institution experience with 43 patients. Ann Oncol.
5:225–231. 1994.
|
|
20
|
de La Motte Rouge T, Pautier P, Rey A, et
al: Prognostic factors in women treated for ovarian yolk sac
tumour: a retrospective analysis of 84 cases. Eur J Cancer.
47:175–182. 2011.
|
|
21
|
Kawai M, Kano T, Furuhashi Y, et al:
Prognostic factors in yolk sac tumors of the ovary. A
clinicopathologic analysis of 29 cases. Cancer. 67:184–192.
1991.
|
|
22
|
Tong X, You Q, Li L, et al: Prognostic
factors of patients with ovarian yolk sac tumors: a study in
Chinese patients. Onkologie. 31:679–684. 2008.
|
